Product Details: AllerControl

AllerControl DISCUSSION: Most standard allergy medications work by targeting histamine. AllerControlTM contains ingredients that target the root causes of histamine release to alleviate allergy symptoms.
60 Vegi-Caps 604 mg AOR04175
100% Vegetarian

SUPPLEMENT FACTS:
Serving Size: 2 Capsules


Perilla Seed extract 100mg

Butterbur Extract (Petasites Japonicus)

167mg
Quercetin 667mg
Luteolin 67mg
Rosmarinic Acid 33mg
Mangiferin 33mg

 

 


Other ingredients: None. Capsule: hypromellose, water.

AOR guarantees that no ingredients not listed on the label have been added to the product. Contains no wheat, gluten, corn, nuts, soy, eggs, dairy, fish or shellfish.

Suggested Use
Take two capsules daily with/without food or as directed by a qualified health care practitioner.

Main Applications
* Blocks the production of allergic responses
* Relieves symptoms of allergy

Source
Multi-Sourced

Pregnancy / Nursing
None.

Cautions
None known.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide medical advice to individuals. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes. Any reproduction in whole or part and in print or electronic form without express permission is strictly forbidden. Permission to reproduce selected material may be granted by contacting AOR Inc.

Copyright © 2005, Advanced Orthomolecular Research

AllerControl Allergies- pain without gain
Allergies are a common problem that affects 20% of Americans, and the prevalence of allergy has lately been on the rise. Allergies are caused by a glitch in the immune system. In any normal immune system, plasma cells produce proteins called antibodies, which patrol the body like tiny police officers in search of proteins that are foreign to the body and signal the presence of a problematic invader. When antibodies find such an invader, they alert the immune cell authorities to trigger an immune response. The least common kind of antibody, immunoglobulin E (IgE), is normally present in very low amounts and is only used to set off an immune reaction in response to a parasitic infection.
However, some people have hereditary predispositions to react to harmless compounds (allergens) such as food proteins, animal hair proteins, plant pollens, drugs, or substances like latex. IgE antibodies bind to immune cells called mast cells and basophils, which are concentrated in skin and mucous membrane surfaces. When the body is exposed to the allergen recognized by IgE, the antibody tells the cells to "degranulate", releasing all kinds of signaling mediators including histamine. These mediators immediately act on surrounding tissues to make blood vessels dilate and smooth muscle contract. Depending on where the allergen is found, this reaction will produce symptoms ranging from irritated sinuses to itchy skin to breathing difficulties.

Allergies can be combated by blocking the allergic response or by targeting inappropriate inflammation, which lies at the root of allergic symptoms. Aller-Control contains several natural compounds that work together to relieve the misery of allergies.

Perilla
Perilla frutescens is a plant whose leaves are commonly used as a garnish with raw fish in Japan. It is also used in Chinese herbal medicine. The functional components of perilla are flavonoid aglycones such as luteolin, apigenin, and rosmarinic acid, all of which have been studied for their anti-allergic and anti-inflammatory potential. One study assessed the clinical features of patients with asthma who had been given perilla seed oil for 4 weeks and found that breathing measurements were significantly increased compared to asthmatics who had not been treated.

Another study observed the effects of perilla seed extracts in volunteers with allergic symptoms such as sneezing, nasal obstruction, and itchy skin and eyes. 20 participants were given perilla seed extracts for 2-4 weeks, and their change in symptoms was evaluated. Symptoms were improved in all 20 patients, with significant improvements in sneezing (almost 40%), stuffed nose (over 60%) and itchy eyes (50%).

Luteolin
Luteolin is considered by many scientists to be the major active constituent in Perilla frutescens. Studies of this component have found that it exerts antimutagenic and anti-inflammatory-allergic effects. It is also recognized as an antioxidant scavenger of damaging free radicals, and as an inhibitor of protein kinase C, which is a key regulator in the initiation of inflammatory events such as smooth muscle constriction. In a mouse model that mimics some of the characteristic features of asthma, orally administered luteolin significantly decreased airway hyperactivity.

Rosmarinic acid
Rosmarinic acid is an extract that is found in plants such as rosemary and perilla. A randomized, double-blind, age-matched placebo-controlled parallel group study observed the effects of rosmarinic acid on 30 patients with seasonal allergic rhinoconjunctivitis (SAR). At the end of the trial period, there was a significant relief of itchy nose, watery eyes, itchy eyes and total symptoms. 55.6-70% of patients given rosmarinic acid reported global symptom relief, compared to only 30% of the placebo group.

Rosmarinic acid is well absorbed from the gastrointestinal tract and besides its effects on allergies, it has therapeutic potential in dealing with or preventing spasmogenic disorders, peptic ulcers, inflammatory diseases, liver toxicity, atherosclerosis, ischemic heart disease, and even cancer.

Quercetin
Quercetin is the most widely consumed flavonoid in the diet and has been used to treat a variety of complaints. Cellular and animal studies have found it to be a potent inhibitor of allergic and inflammatory responses. It is also a powerful antioxidant, and has benefits in heart health and diabetic complications. High intakes of quercetin are linked to lower mortality rates and heart attack incidence.

Mangiferin
Mangiferin is an extract of the plant Mangifera indica L. This plant is used in Cuba to help with various disorders including bronchial asthma, atopic dermatitis, and other allergic diseases. It has been reported to have antispasmodic, antimicrobial and fever-reducing effects. Mangiferin is the dominant component of this plant, and has strong anti-allergic effects. It also has antiviral, anti-tumour and antioxidant activity.

Butterbur
Butterbur (petasites hybridus) is a shrub found in Europe and in parts of Asia and North America. A study of patients with asthma or bronchitis found that butterbur improved lung ventilation and bronchial reactivity. Another study found that petasites had a comparable effect to the antihistamine cetirizine for seasonal allergic rhinitis, likely due to its effectiveness at reducing nasal responsiveness. It did not have the sedative effect associated with the drug.

Migraines are another disorder characterized by inappropriate inflammation, and in a double-blind placebo-controlled study, butterbur supplementation led to up to a 60% decrease in migraine frequency compared to the placebo group, and the migraine symptoms decreased in duration and intensity.

Cellular mechanisms
The ingredients in Aller-Control work at a number of levels to block allergic responses and alleviate the associated symptoms. Quercetin, mangiferin, and perilla and its extracts block the production of IgE, thereby inhibiting the allergic response from developing in the first place. Several of the compounds are able to stabilize mast cells to prevent them from degranulating and releasing histamine and other pro-inflammatory mediators. Perilla selectively blocks the activity of 5-lipooxygenase and quercetin blocks cyclooxygenases and lipooxygenases, which are enzymes that produce these mediators. Rosmarinic acid inhibits a key step of the complement system, which is an alternate pathway of inflammation. Luteolin, rosmarinic acid, quercetin and resveratrol are all effective at blocking the production of pro-inflammatory cytokines.

Some of the cytokines that are primarily responsible for allergic diseases include interleukin (IL)-4 and IL-5. IL-4 is one of the most important cytokines in the production of IgE and allergic inflammation. IL-5 is responsible for recruiting eosinophils, which are immune cells that assist in priming the immune system for an allergic response and are responsible for releasing pro-inflammatory mediators. Eosinophil accumulation is a distinctive feature of allergic inflammation. Luteolin, rosmarinic acid, quercetin and mangiferin are all able to block the production of IL-4 and IL-5, and the subsequent recruitment and activation of eosinophils.

For those who are sick of dealing with itching, sneezing, watery eyes, difficulty breathing, or even worse symptoms, the compounds of Aller-Control are brought together to provide a natural solution for allergies.

References

Ueda H, Yamazaki C and Yamazaki M. Luteolin as an anti-inflammatory and anti-allergic constituent of Perilla frutescens. Biol Pharm. Bull. 2002;25(9):1197-1202.

Makino T, Furuta Y, Wakushima H, Fujii H, Saito K and Kano Y. Effect of oral treatment of Perilla frutescens and its constituents on type-I allergy in mice. Biol. Pharm. Bull. 2001;24(10):1206-1209.

Makino T, Furuta Y, Wakushima H, Fujii H, Saito K and Kano Y. Anti-allergic effect of Perilla frutescens and its active constituents. Phytotherapy Research. 2004;17:240-243.

Okamoto M, Mitsunobu F, Ashida K, Mifune T, Hosaki Y, Tsugeno H, Harada S, Tanizaki Y, Kataoka M, Niiya K, Harada M. Effects of perilla seed oil supplementation on leukotriene generation by leukocytes in patients with asthma associated with lipometabolism. Int Arch Allergy Immunol. 2000 Jun;122(2):137-42.

Kimata M, Shichijo M, Miura T, Serizawa I, Inagaki N and Nagai H. Effects of luteolin, quercetin and baicalein on immunoglobulin E-mediated mediator release from human cultured mast cells. Clinical and Experimental Allergy. 2000;30:501-508.

Sanbongi C, Takano H, Osakabe N, Sasa N, Natsume M, Yanagisawa R, Inoue K-I, Sadakane K, Icinose T and Yoshikawa T. Rosmarinic acid in perilla extract inhibits allergic inflammation induced by mite allergen, in a mouse model. Clin Exp Allergy. 2004;34:971-977.

Das M, Ram A and Ghosh B. Luteolin alleviates bronchoconstriction and airway hyperreactivity in ovalbumin sensitized mice. Inflammation Research. 2003;52:101-106.

Takano H, Osakabe N, Sanbongi C, Yanagisawa R, Inoue K-I, Yasuda A, Natsume M, Baba S, Ichiishi E-I and Yoshikawa T. Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, inhibits seasonal allergic rhinoconjunctivitis in humans. Exp Biol Med. 2004;229:247-254.

Al-Sereitia MR, Abu-Amerb KM and Sena P. Pharmacology of rosemary (Rosemarinus officinalis Linn.) and its therapeutic potentials. Indian Journal of Experimental Biology. 1999;37:124-131.

Rivera DG, Balmaseda IH, Leon AA, Hernandez BC, Montiel LM, Garrido GG, Cuzzocrea S and Hernandez RD. Anti-allergic properties of Mangifera indica L. extract (Vimang) and contribution of its glucosylxanthone mangiferin. Journal of Pharmacy and Pharmacology. 2006;58:385-392.

Garcia D, Delgado R, Ubeira FM, Leiro J. Modulation of rat macrophage function by the Mangifera indica L. extracts Vimang and mangiferin. International Immunopharmacology. 2002;2:797-806.

Sa-Nunes A, Rogerio AP, Medeiros AI, Fabris VE, Andreu GP, Rivera DG, Delgado R and Faccioli LH. Modulation of eosinophil generation and migration by Mangifera indica L. extract (Vimang). International Immunopharmacology. 2006;6(9):1515-1523.

Baolin L, Inami Y, Tanaka H, Inagaki N, Tinuma M, Nagai H. Resveratrol inhibits the release of mediators from bone marrow-derived mouse mast cells in vitro. Planta Med. 2004;70(4):305-309.

Danesch UC. Petasites hybridus (Butterbur root) extract in the treatment of asthma- an open trial. Altern Med Rev. 2004;9(1):54-62.

Lee DKC, Carstairs IJ, Haggart K, Jackson CM, Currie GP and Lipworth BJ. Butterbur, a herbal remedy, attenuates adenosine monophosphate induced nasal responsiveness in seasonal allergic rhinitis. Clin Exp Allergy. 2003;33:882-886.

The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide medical advice to individuals. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes. Any reproduction in whole or part and in print or electronic form without express permission is strictly forbidden. Permission to reproduce selected material may be granted by contacting AOR Inc.

Copyright © 2005, Advanced Orthomolecular Research

No articles found

Extract of Perilla frutescens Enriched for Rosmarinic Acid, a Polyphenolic Phytochemical, Inhibits Seasonal Allergic Rhinoconjunctivitis in Humans
Exp Biol Med. 2004;229:247-254.
Takano H, Osakabe N, Sanbongi C, Yanagisawa R, Inoue K-I, Yasuda A, Natsume M, Baba S, Ichiishi E-I and Yoshikawa T.


Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, suppresses allergic immunoglobulin responses and inflammation caused by polymorphonuclear leukocytes (PMNL) in mice. However, few placebo-controlled clinical trials have examined the efficacy and safety of polyphenolic phytochemicals for treatment of allergic inflammatory diseases in humans. The present study determined whether oral supplementation with rosmarinic acid is an effective intervention for patients with seasonal allergic rhinoconjunctivitis (SAR). In this 21-day, randomized, double-blind, agematched, placebo-controlled parallel group study, patients with mild SAR were treated daily with extract of Perilla frutescens enriched for rosmarinic acid (200 mg [n 5 10] or 50 mg [n 5 9]) or placebo (n 5 10). Patients recorded symptoms daily in a diary. Profiles of infiltrating cells and concentrations of eotaxin, IL-1b, IL-8, and histamine were measured in nasal lavage fluid. Serum IgE concentrations and routine blood tests were also examined. As compared with placebo supplementation, supplementation with extract of Perilla frutescens enriched for rosmarinic acid resulted in a significant increase in responder rates for itchy nose, watery eyes, itchy eyes, and total symptoms (P < 0.05). Active treatment significantly decreased the numbers of neutrophils and eosinophils in nasal lavage fluid (P < 0.05 vs. placebo). Patients reported no adverse events, and no significant abnormalities were detected in routine blood tests. In conclusion, extract of Perilla frutescens enriched for rosmarinic acid can be an effective intervention for mild SAR at least partly through inhibition of PMNL infiltration into the nostrils. Use of this alternative treatment for SAR might reduce treatment costs for allergic diseases.


Petasites hybridus (Butterbur root) extract in the treatment of asthma--an open trial.
Altern Med Rev. 2004 Mar;9(1):54-62.
Danesch UC.


The efficacy and tolerability of a butterbur root extract (Petadolex) for the treatment of asthma was analyzed in a prospective, non-randomized, open trial. Subjects included 64 adults and 16 children/adolescents treated for two months with the extract, followed by two months during which the intake of the extract was optional. Concomitant asthma medication was permitted. The number, duration, and severity of asthma attacks decreased, while peak flow, forced expiratory volume (FEV1), and all measured symptoms improved during therapy. In addition, more than 40 percent of patients using asthma medications at baseline reduced intake of these medications by the end of the study. This study suggests the Petasites hybridus extract Petadolex is an effective and safe therapy for the treatment of asthma.


Anti-inflammatory activity of quercetin and isoquercitrin in experimental murine allergic asthma.
Infl amm. res. 2007; 56:402-408.
Rogerio1 AP, Kanashiro A, Fontanari1 C, da Silva1 EVG, Lucisano-Valim YM, Soares EG and Faccioli1 LH.


OBJECTIVE: Eosinophils and cytokines are implicated in the pathogenesis of allergic diseases. In the present study, we investigate the anti-infl ammatory effect of quercetin and isoquercitrin in a murine model of asthma.
METHODS: BALB/c mice were immunized (ovalbumin/aluminum hydroxide, s. c.), followed by two intranasal ovalbumin challenges. From day 18 to day 22 after the fi rst immunization, the mice received daily gavages of isoquercitrin (15 mg/ kg) or quercetin (10 mg/kg). Dexamethasone (1 mg/kg, s. c.) was administered as a positive control. Leucocytes were analyzed in bronchoalveolar lavage fl uid (BALF), blood and pulmonary parenchyma at 24 h after the last ovalbumin challenge. Interleukin-5 (IL-5) was analyzed in BALF and lung homogenates.
RESULTS: In animals receiving isoquercitrin or quercetin, eosinophil counts were lower in the BALF, blood and lung parenchyma. Neutrophil counts in blood and IL-5 levels in lung homogenate were lower only in isoquercitrin-treated mice. No alterations in mononuclear cell numbers were observed.
CONCLUSION: Quercetin and isoquercitrin are effective eosinophilic inflammation.


Butterbur, a herbal remedy, attenuates adenosine monophosphate induced nasal responsiveness in seasonal allergic rhinitis.
Clin Exp Allergy. 2003 Jul;33(7):882-6.
Lee DK, Carstairs IJ, Haggart K, Jackson CM, Currie GP, Lipworth BJ.


BACKGROUND: Butterbur (BB) or Petasites hybridus, a herbal remedy, exhibits in vitro inhibition of cysteinyl leukotriene biosynthesis. However, no placebo-controlled studies have been performed to evaluate the effectiveness of BB on objective outcomes such as nasal provocation testing in seasonal allergic rhinitis (SAR).
METHODS: Twenty patients with grass-pollen-sensitized SAR were randomized in a double-blind, cross-over manner to receive for 2 weeks either BB 50 mg twice daily or placebo (PL) twice daily during the grass pollen season. Nasal adenosine monophosphate (AMP) challenge (the primary outcome) was administered as a single 400 mg/mL dose after each randomized treatment.
RESULTS: Spontaneous recovery following AMP challenge (area under the response time profile curve as % x min+/-SEM) was significantly attenuated (P=0.028) with BB (584+/-289) compared to PL (1438+/-240); mean difference: 854 (95% CI 95-1614), and the maximum % peak nasal inspiratory flow reduction from baseline following AMP challenge was significantly blunted (P=0.036) with BB (30+/-4) compared to PL (43+/-5); mean difference: 13 (95% CI 1-25).
CONCLUSIONS: BB exhibited protection against AMP-induced nasal responsiveness during the grass pollen season in sensitized patients. This is turn may explain its potential clinical efficacy in patients with SAR.


The information and product descriptions appearing on this website are for information purposes only, and are not intended to provide medical advice to individuals. Consult with your physician if you have any health concerns, and before initiating any new diet, exercise, supplement, or other lifestyle changes. Any reproduction in whole or part and in print or electronic form without express permission is strictly forbidden. Permission to reproduce selected material may be granted by contacting AOR Inc.

Copyright © 2005, Advanced Orthomolecular Research

Insider Updates coming soon

Below are the questions and answers that have been assigned to this product. Click on the question to view its details.

Public FAQs

Q: What is Sorbitol and Why Is It Used In AORs Capsules?
A: Sorbitol, also known as glucitol, is a highly ubiquitous and naturally-occurring substance found in everything from the biochemistry of the human body to apples to chewing gum. The latter of course contains the synthetic version, and in the supplement industry sorbitol is used in capsules, tablets and softgels. Its most common roles are that of a plasticizer (to reduce capsule brittleness and enhance stability) and as a humectant (to reduce long-term leakage). Sorbitol is one of the most effective and widely used substances in the world for these and other similar purposes, spanning the food, pharmaceutical, and natural supplement industries. It holds GRAS (Generally Recognized As Safe) status with the FDA in the United States and in Canada is listed on the Ministry of Health's list of Acceptable Non-medicinal Ingredients with a composition allowance of 90%, one of the highest of any non-medicinal ingredients. However, as of March of 2009, the capsules of AOR products will no longer contain sorbitol as a constituent.